Neurostimulation Devices Market To Reach A Valuation Of ~Us$ 15.3 Bn By 2027

1
Neurostimulation Devices Market (Product Spinal
Cord Stimulators, Deep Brain Stimulators,
Cochlear Implants, Vagus Nerve Stimulators,
Sacral Nerve Stimulators, Percutaneous Tibial
Nerve Stimulators, and Transcranial Magnetic
Stimulators Application Chronic Pain, Movement
Disorders, Hearing Impairment, Epilepsy, Urinary
Incontinence, and Major Depressive Disorder End
User Hospitals, Ambulatory Surgery Centers, and
Specialty Clinics)Forecast From 2019 - 2027
Neurostimulation Devices Market
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 Global Neurostimulation Devices Market, Key Insights
Chapter 6 Global Neurostimulation Devices Market Analysis and Forecast, by Product
Chapter 7 Global Neurostimulation Devices Market Analysis and Forecast, by Application
Chapter 8 Global Neurostimulation Devices Market Analysis and Forecast, by End-user
Chapter 9 Global Neurostimulation Devices Market Analysis and Forecast, by Region
Chapter 10 North America Neurostimulation Devices Market Analysis and Forecast
Chapter 11 Europe Neurostimulation Devices Market Analysis and Forecast
Chapter 12 Asia Pacific Neurostimulation Devices Market Analysis and Forecast
Chapter 13 Latin America Neurostimulation Devices Market Analysis and Forecast
Chapter 14 Middle East and Africa Neurostimulation Devices Market Analysis and Forecast
Chapter 15 Competition Landscape 
3
Neurostimulation Devices Market Snapshot

• Neurostimulation device sends mild electric
  pulses to the damaged nerves at specific parts of
  brain, spinal cord, and peripheral nervous system
  to treat various medical conditions.
• Rise in the number of patients with chronic pain
  and neurological disorders across the globe and
  new product developments are anticipated to fuel
  the growth of the global neurostimulation devices
  market.
• global neurostimulation devices market has been
  segmented based on product, application, end
  user, and region.

4
(No Transcript)
5
Reports Highlights

• Global neurostimulation devices market was valued
  at US 6.3 Bn in 2018, and is projected to
  expand at a high CAGR from 2019 to 2027.
• Key Players Nevro Corp., LivaNova plc, Axonics
  Modulation Technologies, Inc., Neuropace, Inc.,
  EndoStim, Inc., NDI Medical, Cochlear Limited,
  and Neuronetics, Inc.

Request Sample
6
(No Transcript)